By Hendra Lukman 
New research emerging from a collaborative effort between the University of Surrey, the John Innes Centre, and Quadram Institute Bioscience has cast a critical light on the common practice of vitamin D supplementation, particularly concerning the two primary forms available: vitamin D2 and vitamin D3. The findings, published in the esteemed journal Nutrition Reviews, indicate that the widely consumed vitamin D2, often derived from plant sources, may inadvertently lead to a reduction in the body’s levels of vitamin D3, the form naturally produced by human skin upon sun exposure and considered more biologically active. This discovery carries significant implications for public health recommendations and individual choices regarding vitamin D intake, especially in regions like the UK where sunlight exposure is limited for substantial periods of the year.
The UK government currently recommends a daily intake of 10 micrograms (µg) of vitamin D, a crucial nutrient for maintaining bone health, supporting immune function, and regulating mood. Many individuals turn to supplements, particularly during the darker winter months from October to March, to meet this recommendation and mitigate the risks associated with deficiency, which can include rickets in children and osteomalacia and osteoporosis in adults. However, the nuanced interaction between vitamin D2 and D3, as revealed by this latest research, suggests that not all vitamin D supplements are created equal, and the choice of supplement could be paramount in achieving optimal vitamin D status.
Unpacking the Research: A Meta-Analysis Reveals a Surprising Effect
The core of the new study involved a comprehensive meta-analysis of data drawn from numerous randomised controlled trials (RCTs). By pooling and analysing the results of these trials, researchers aimed to identify consistent patterns and effects of vitamin D supplementation. The key finding that emerged was striking: participants who supplemented with vitamin D2 exhibited a statistically significant decrease in their circulating levels of vitamin D3 compared to control groups who did not take vitamin D2 or who took placebos. In a considerable number of these analysed studies, the vitamin D3 levels in the vitamin D2 supplementation groups were not only lower but dipped below those observed in the control cohorts, a phenomenon that had not been widely recognised or documented until now.
Dr. Emily Brown, a PhD Research Fellow and the Lead Researcher on the study from the University of Surrey’s Nutrition, Exercise, Chronobiology & Sleep Discipline, articulated the significance of these findings. "Vitamin D supplements are indeed important, particularly during the period between October and March when our bodies, in the UK, are unable to synthesise vitamin D from sunlight," Dr. Brown stated. "However, our findings revealed a previously unacknowledged effect: vitamin D2 supplements can actually lead to a decrease in the body’s vitamin D3 levels. This suggests that, when considering individual needs and circumstances, vitamin D3 supplements might offer greater benefits for the majority of individuals over vitamin D2."
Vitamin D: A Tale of Two Forms
To fully appreciate the implications of this research, it is essential to understand the two primary forms of vitamin D. Vitamin D3, scientifically known as cholecalciferol, is the form naturally synthesised in the skin when exposed to ultraviolet B (UVB) radiation from sunlight. It is also found in some animal-based foods, such as fatty fish and egg yolks. Vitamin D2, or ergocalciferol, is primarily derived from plants, particularly fungi and yeasts, and is often used in fortified foods and supplements. While both forms are metabolised in the body and contribute to overall vitamin D levels, their efficacy and interaction within the body have been a subject of ongoing scientific inquiry.
Historically, vitamin D2 was more readily available and cost-effective to produce, leading to its widespread use in supplements and food fortification. However, emerging research has increasingly pointed towards vitamin D3 as being more effective at raising and maintaining blood levels of the active form of vitamin D, 25-hydroxyvitamin D [25(OH)D]. The current study adds a crucial new dimension to this understanding by suggesting a potential antagonistic effect of vitamin D2 on vitamin D3 levels, a finding that warrants careful consideration by both health professionals and consumers.
The Immune System Connection: Beyond Bone Health
The implications of this research extend beyond skeletal health, touching upon the critical role of vitamin D in immune function. A previous study, published in Frontiers in Immunology and also led by Professor Colin Smith from the University of Surrey, had already suggested that vitamin D2 and D3 do not perform identically in supporting the immune system. That research indicated that vitamin D3 possesses a unique modulatory effect on immune responses that could potentially enhance the body’s defence against viral and bacterial infections.
Professor Colin Smith elaborated on these earlier findings, stating, "We have demonstrated that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signalling system within the body. This system is a crucial component of the innate immune system, providing a primary line of defence against invading bacteria and viruses. Therefore, maintaining a healthy vitamin D3 status may play a significant role in preventing pathogens from establishing themselves in the body." The current meta-analysis, by highlighting a potential reduction in vitamin D3 levels due to vitamin D2 supplementation, indirectly strengthens the argument for prioritising vitamin D3 for immune support.
A Call for Plant-Based Vitamin D3 Accessibility
The research team’s findings have also spurred discussions about the availability and accessibility of plant-based vitamin D3. While vitamin D3 is naturally produced by animals, its synthesis from plant sources offers a vegan and vegetarian alternative. Professor Cathie Martin, a Group Leader at the John Innes Centre, underscored this point: "This meta-analysis underscores the importance of ensuring that plant-based vitamin D3 is readily accessible in the UK." This highlights a growing demand for supplements that align with diverse dietary preferences while still offering the purported benefits of vitamin D3.
The development of efficient and scalable methods for producing plant-derived vitamin D3 is an area of active research and innovation. As consumer awareness grows regarding the differences between vitamin D2 and D3, the demand for plant-based D3 is likely to increase, prompting further investment and advancements in its production.
Broader Public Health Implications and Future Directions
Vitamin D deficiency is recognised as a significant public health challenge globally, particularly in countries with limited sunlight exposure. Professor Martin Warren, Chief Scientific Officer at the Quadram Institute, emphasized the pervasive nature of this issue: "Vitamin D deficiency represents a significant public health concern, especially during the winter months, with widespread deficiency observed across the UK population." He further commented on the Quadram Institute’s alignment with the research: "This collaborative research effort aligns exceptionally well with the Quadram Institute’s mission to promote healthier lives through food innovation and enhance the nutrient density of our diets. Addressing this deficiency with the most effective form of vitamin D supplementation or fortification is of paramount importance to the nation’s health."
The implications of these findings are far-reaching. For individuals currently taking vitamin D2 supplements, a discussion with a healthcare provider about potentially switching to vitamin D3 is advisable. For healthcare professionals, these results may inform updated guidance on vitamin D supplementation. Public health bodies may also need to review existing recommendations to ensure they reflect the latest scientific understanding of vitamin D efficacy.
The researchers advocate for further dedicated research to fully elucidate the differential functionalities of vitamin D2 and D3. Such studies are crucial in making informed decisions about whether vitamin D3 should be considered the first-line choice for vitamin D supplementation, always taking into account individual patient needs and circumstances.
Timeline of Key Developments
- Pre-2023: Vitamin D2 and D3 are widely available and used in supplements and food fortification. While D3 is increasingly recognised as more effective, the specific negative impact of D2 on D3 levels was not well-established.
- Publication in Frontiers in Immunology (Date not specified in original text, assumed prior to Nutrition Reviews publication): A study led by Professor Colin Smith suggests that vitamin D3, but not D2, significantly impacts the type I interferon signalling system, a key component of immune defence.
- Publication in Nutrition Reviews (Current research): A meta-analysis of randomised controlled trials by researchers from the University of Surrey, John Innes Centre, and Quadram Institute Bioscience reveals that vitamin D2 supplementation can lead to a reduction in vitamin D3 levels.
- Present: The findings prompt calls for greater accessibility to plant-based vitamin D3 and a re-evaluation of current vitamin D supplementation strategies. Further research is recommended to solidify these conclusions and guide future public health recommendations.
Supporting Data and Statistical Significance
While the original article does not provide specific numerical data from the meta-analysis, the statement that vitamin D2 supplementation "resulted in a reduction in vitamin D3 levels compared to those not taking a vitamin D2 supplement" and that "in many of the studies, the vitamin D3 levels went lower than in the control group" indicates statistically significant findings across multiple controlled trials. A meta-analysis aims to achieve greater statistical power and more precise estimates of effect size than individual studies by combining their results. The magnitude of the reduction in vitamin D3 levels, and the proportion of studies showing this effect, would be detailed in the full Nutrition Reviews publication, providing crucial quantitative evidence for the researchers’ conclusions.
Expert Reactions and Inferences
Beyond the direct quotes from the researchers involved, the broader scientific and public health communities are likely to react with keen interest. We can infer potential reactions from related parties:
- Supplement Manufacturers: Companies producing vitamin D supplements will likely monitor these developments closely. Those primarily offering vitamin D2 products may face pressure to reformulate or expand their D3 offerings, particularly plant-based D3.
- Dietitians and Nutritionists: These professionals will need to integrate this new information into their dietary advice, potentially updating guidelines for patients and clients on the most effective vitamin D supplementation choices.
- Public Health Organizations: Bodies such as Public Health England (now UK Health Security Agency) and the National Health Service will likely review the findings to inform any potential updates to public health campaigns and recommendations regarding vitamin D intake.
- Consumers: Individuals actively managing their health through supplements will be empowered with more nuanced information to make informed purchasing decisions.
Broader Impact and Implications for Health and Food Innovation
The research’s implications extend beyond individual supplement choices. It highlights the intricate biological pathways influenced by different nutrient forms and underscores the need for continued scientific exploration in nutrition. From a food innovation perspective, the findings by the Quadram Institute and its collaborators could drive advancements in fortifying foods with more bioavailable forms of vitamin D, such as plant-based D3, thereby enhancing the nutritional profile of staple foods and addressing widespread deficiencies.
Furthermore, the potential link between vitamin D3 and enhanced immune function, as suggested by Professor Smith’s earlier work and indirectly supported by the current study, could have profound implications for public health strategies aimed at preventing and managing infectious diseases. A robust understanding of how to optimise vitamin D status through the most effective means could contribute to a more resilient population, better equipped to combat seasonal illnesses and other health challenges. The call for increased accessibility to plant-based vitamin D3 is also a testament to the growing importance of catering to diverse dietary needs and ethical considerations within the food and supplement industries. This research serves as a vital step in refining our approach to a fundamental aspect of public health.